Drug Database
Back to search

France· FR:66766366

AGRASTAT 250 microgrammes/ml, solution à diluer pour perfusion

A tirofiban product, registered in France by ADVANZ PHARMA LIMITED. The same ATC class is registered in 11 of our 19 countries.

ATC B01AC17

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedAGRASTAT 250 microgrammes/ml, solutio…ATCB01AC17REGISTER NO.FR:66766366PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about AGRASTATAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tirofiban is registered in 11 of 19 countries.

Countries holding a registration under ATC B01AC17 (tirofiban), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 7 of them publish a price we can compare per daily dose
Search tirofiban products by name

Tirofiban · ATC B01AC17

11 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Franceprice
  • Germany
  • Netherlands
  • Norwayprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Manufacturer
ADVANZ PHARMA LIMITED
Country
France (FR)
ATC code
B01AC17
ATC class
Tirofiban
Defined daily dose
10 mg, P
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400956216758
    1 flacon(s) en verre de 50 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

159 interactions on record for tirofiban.

Graded by severity as the source publishes them — 62 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check tirofiban against other medicinesHow interaction checks work

Tirofiban · interactions on record

159 records

  • 62 severe
  • 75 moderate
  • 22 info

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • HeparinB01AB01severe
  • DalteparinB01AB04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tirofiban in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tirofiban products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Austria · Aggrastat
  • Belgium · Aggrastat
  • Bulgaria · Аграстат, Тирофибан Чайкафарма
  • Cyprus · Aggrastat, Αggrafiban
  • Germany · Aggrastat, Tirofiban Ibisqus
  • Estonia · Aggrastat
  • Spain · Agrastat, Tirofiban Altan Pharmaceuticals S.A.
  • Finland · Aggrastat
  • United Kingdom (Northern Ireland) · Aggrastat, Tirofiban Eugia (Uk)
  • Greece · Aggrastat, Αggrafiban
  • Hungary · Aggrastat
  • Italy · Aggrastat, Tirofiban Aurobindo
  • Lithuania · Aggrastat
  • Luxembourg · Aggrastat
  • Latvia · Aggrastat
  • Malta · Aggrastat, Tirofiban Ibigen
  • Netherlands · Aggrastat, Tirofiban Eugia
  • Portugal · Tirofibano, Tirofibano Generis
  • Sweden · Aggrastat

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e85f8c32-cd19-4bb6-98bd-8517a7ffd75b
GET /v1/drugs/e85f8c32-cd19-4bb6-98bd-8517a7ffd75b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "66766366",
  "date_amm": "1999-07-30",
  "type_amm": "Procédure de reconnaissance mutuelle",
  "numero_ue": null,
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution à diluer pour perfusion",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about tirofiban.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console